Natural Antidiabetic Agents: Current Evidence and Development Pathways from Medicinal Plants to Clinical use
Open Access
- 16 March 2025
- journal article
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (3)
Abstract
Diabetes mellitus is a long-term metabolic condition marked by chronically high levels of glucose in the blood due to insufficient synthesis of insulin or impaired insulin function. Throughout history, several civilizations have used traditional medicinal plants to treat and control diabetes. This paper offers a thorough review, to date, of the antidiabetic natural compounds of medicinal plants origin, specifically highlighting their reported modes or mechanisms of action and therapeutic possibilities, with a view to fast-tracking the possibility of their transition to pharmaceutical products for human use. Phytochemicals such as flavonoids, alkaloids, terpenoids, and glycosides have notable antidiabetic effects. They have been shown to control blood glucose levels via many processes, including boosting insulin secretion, improving insulin sensitivity, blocking glucose absorption in the \gastrointestinal-tract, and regulating carbohydrate metabolism. Unlike earlier reviews, this current one, in addition to the chemistry and proposed mechanisms of action, also x-rays the effectiveness and safety of these natural chemicals by combining evidences from laboratory research, animal experiments, and clinical trials. Several substances, such as Demethoxycurcumin, Trigonelline, and Ginsenosides, have progressed to clinical trials, while others like Allicin and Polypeptide-p have been used at the bedside. Several substances, including Bisdemethoxycurcumin, Vicine, and Gymnemosides, are now in the preclinical trial phase, suggesting that research is still ongoing and there is promise for their future medicinal application. The review highlights the evolution of chemicals in diabetes management, highlighting their potential to improve treatment. It suggests incorporating plant-derived compounds into traditional treatments, reducing dependence on drugs and reducing adverse effects.Keywords
This publication has 280 references indexed in Scilit:
- Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: A comprehensive reviewFood Science & Nutrition, 2024
- Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC–MS/MS in Sprague–Dawley ratsBiomedical Chromatography, 2023
- Promising influences of gingerols against metabolic syndrome: A mechanistic reviewBioFactors, 2022
- Role of stilbenes against insulin resistance: A reviewFood Science & Nutrition, 2021
- Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathwayJournal of Cellular Biochemistry, 2019
- Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complicationsJournal of Cellular Physiology, 2019
- Possible molecular mechanisms of glucose‐lowering activities of Momordica charantia (karela) in diabetesJournal of Cellular Biochemistry, 2019
- Curcumin: A Naturally Occurring Modulator of Adipokines in DiabetesJournal of Cellular Biochemistry, 2017
- Mangiferin modulation of metabolism and metabolic syndromeBioFactors, 2016
- Bitter Melon Extracts Enhance the Activity of Chemotherapeutic Agents Through the Modulation of Multiple Drug ResistanceJournal of Pharmaceutical Sciences, 2013